Costs for genomic sequencing have dropped steeply, making new types of genetic tests more accessible and changing the business model for the labs that run them.
Education
- PhD, Materials, University of California, Santa Barbara
- MS, University of Virginia School of Engineering and Applied Science
- BTech, Indian Institute of Technology, Bombay
Honors and Awards
- Holds more than 40 patents
Srikant Vaidyanathan joined Boston Consulting Group in 2003 and has worked in the Chicago and Zurich offices. He is a core member of the firm’s Health Care; Marketing, Sales & Pricing; and Operations practices. He leads BCG’s market access and pricing work worldwide and is an expert in technical operations across the value chain in both small molecules and biologics.
Srikant is a BCG Institute Fellow working on how health equity can be embedded into the strategy and governance of companies and how that can translate into sustained outcomes, among other topics.
Before joining BCG, Srikant worked at Corning in the US for five years. While there, he took several products from concept to market.
